118
Views
12
CrossRef citations to date
0
Altmetric
Letters to the Editor

Progressive multifocal leukoencephalopathy after rituximab in a patient with relapsed follicular lymphoma and low IgG levels and a low CD4+ lymphocyte count

, , , , , , , & show all
Pages 2367-2369 | Received 22 Jul 2008, Accepted 09 Aug 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ron Ram, Isaac Ben-Bassat, Ofer Shpilberg, Aaron Polliack & Pia Raanani. (2009) The late adverse events of rituximab therapy – rare but there!. Leukemia & Lymphoma 50:7, pages 1083-1095.
Read now
Kenneth R. Carson & Charles L. Bennett. (2009) Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating. Leukemia & Lymphoma 50:3, pages 323-324.
Read now

Articles from other publishers (10)

Ikreet Cheema, Nicole Ng & Tychicus Chen. (2021) Clinical Reasoning: A 71-Year-Old Man With Horizontal Gaze Palsy, Anarthria, and Quadriparesis. Neurology 96:24, pages 1146-1150.
Crossref
Roderick P. P. W. M. Maas, Annemarie H. G. Muller-Hansma, Rianne A. J. Esselink, Jean-Luc Murk, Clemens Warnke, Joep Killestein & Mike P. Wattjes. (2016) Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases. Journal of Neurology 263:10, pages 2004-2021.
Crossref
Michael J. Hoffman & Valentina Stosor. 2014. Infectious Complications in Cancer Patients. Infectious Complications in Cancer Patients 253 298 .
Rebecca C Selter, Viola Biberacher, Verena Grummel, Dorothea Buck, Christian Eienbröker, Wolfgang H Oertel, Achim Berthele, Björn Tackenberg & Bernhard Hemmer. (2013) Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients. Multiple Sclerosis Journal 19:11, pages 1454-1461.
Crossref
Daniel L. Keene, Carole Legare, Elaine Taylor, Jim Gallivan, Gloria Mah Cawthorn & Duc Vu. (2014) Monoclonal Antibodies and Progressive Multifocal Leukoencephalopathy. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 38:4, pages 565-571.
Crossref
Victor Mulanovich & Amar Safdar. 2011. Principles and Practice of Cancer Infectious Diseases. Principles and Practice of Cancer Infectious Diseases 207 218 .
Meng Zhang, Fumin Li, Michael Rasper, Ali G. Saad & Santosh Kesari. (2010) Prolonged Stability of Progressive Multifocal Leukoencephalopathy in a Patient With Chronic Lymphocytic Leukemia. Journal of Clinical Oncology 28:28, pages e503-e506.
Crossref
William G. WierdaThomas J. KippsJiří MayerStephan StilgenbauerCathy D. WilliamsAndrzej HellmannTadeusz RobakRichard R. FurmanPeter HillmenMarek TrnenyMartin J.S. DyerSwami PadmanabhanMagdalena PiotrowskaTomas KozakGeoffrey ChanRandy DavisNedjad LosicJoris WilmsCharlotte A. RussellAnders Österborg. (2010) Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia. Journal of Clinical Oncology 28:10, pages 1749-1755.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:6.
Crossref
Kenneth R. CarsonAndrew M. EvensElizabeth A. RicheyThomas M. HabermannDaniele FocosiJohn F. SeymourJacob LaubachSusie D. BawnLeo I. GordonJane N. WinterRichard R. FurmanJulie M. VoseAndrew D. ZelenetzRonac MamtaniDennis W. RaischGary W. DorshimerSteven T. RosenKenji Muro, Numa R. Gottardi-LittellRobert L. TalleyOliver SartorDavid GreenEugene O. Major & Charles L. Bennett. (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113:20, pages 4834-4840.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.